相关实验视频
Updated: Jan 22, 2026

05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
5.3K
激活PDGF通路将LMNA突变与扩张性心肌病相关联
Jaecheol Lee1,2,3,4, Vittavat Termglinchan5,6,7, Sebastian Diecke8,9,10
1Stanford Cardiovascular Institute, Stanford University, Stanford, CA, USA. jaecheol@skku.edu.
Nature
|July 19, 2019
概括
拉明A/C (LMNA) 基因的突变导致扩张性心肌病 (DCM). 向血小板衍生生长因子 (PDGF) 途径可以治疗这种遗传性心脏病.
科学领域:
- 心血管生物学 心血管生物学
- 干细胞生物学 干细胞生物学
- 遗传学 是一个遗传学.
背景情况:
- 拉敏A/C (LMNA) 基因的突变是遗传扩张性心肌病 (DCM) 的常见原因.
- 与LMNA相关的DCM的特征是缩功能受损和心律失常.
- 患者特异性诱导多能干细胞衍生心肌细胞 (iPSC-CMs) 为研究疾病机制提供了一个模型.
研究的目的:
- 通过使用患者衍生的iPSC-CM来研究与LMNA相关的DCM背后的细胞机制.
- 确定与LMNA相关的DCM的潜在治疗点.
主要方法:
- 从具有LMNA突变的患者中生成iPSC-CMs.
- 电生理学研究以评估单细胞水平的心脏功能.
- 在iPSC-CM中分析信号通路,包括血小板衍生生长因子 (PDGF).
主要成果:
- 突变的iPSC-CMs表现出异常的平衡,导致单细胞心律失常.
- 血小板衍生生长因子 (PDGF) 信号通路在具有LMNA突变的iPSC-CM中被激活.
- 抑制PDGF通路可以改善心律失常的表型在体外.
结论:
- 异常的PDGF通路激活有助于LMNA相关DCM的发病.
- PDGF受体-β (PDGFRB) 是LMNA相关DCM的潜在治疗标.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
490
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
490
Covalently Linked Protein Regulators
8.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.7K
Mutations
94.4K
Overview
94.4K
Cardiomyopathy IV: Restrictive Cardiomyopathy
486
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
486
Cardiomyopathy III: Hypertrophic Cardiomyopathy
426
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
426
Viral Mutations
39.8K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.8K

